Sugi Predict

Sugi Predict / Compounds / SCHEMBL2017879

SCHEMBL2017879

SCHEMBL2017879

[CH2]c1cc(OCCCCCCCCCCCCCCCCCC)c(OCCCCCCCCCCCCCCCCCC)c(OCCCCCCCCCCCCCCCCCC)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ THRA P10827 1/20 0.41
▸ THRB P10828 1/20 0.41
▸ TLR8 Q9NR97 1/20 0.40
▸ MEN1 O00255 1/20 0.39
▸ NR1I2 O75469 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ CHRM2 P08172 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ ADRA2A P08913 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ OPRK1 P41145 1/20 0.39
▸ HTR2B P41595 1/20 0.39
▸ SLC6A3 Q01959 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ HDAC6 Q9UBN7 1/20 0.39
▸ NR5A1 Q13285 1/20 0.39
▸ SRC P12931 1/20 0.39
▸ CHUK O15111 1/20 0.39
▸ DAPK3 O43293 1/20 0.39
▸ JAK2 O60674 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5270141 1.00 THRA (0.41) THRATHRBTLR8MEN1NR1I2
SCHEMBL5266350 1.00 THRA (0.41) THRATHRBTLR8MEN1NR1I2
SCHEMBL5270066 1.00 THRA (0.41) THRATHRBTLR8MEN1NR1I2
SCHEMBL5267613 1.00 THRA (0.41) THRATHRBTLR8MEN1NR1I2
SCHEMBL5269365 1.00 THRA (0.41) THRATHRBTLR8MEN1NR1I2
SCHEMBL1187488 1.00 THRA (0.41) THRATHRBTLR8MEN1NR1I2
SCHEMBL5270597 1.00 THRA (0.41) THRATHRBTLR8MEN1NR1I2
SCHEMBL5267689 1.00 THRA (0.41) THRATHRBTLR8MEN1NR1I2
SCHEMBL1920764 1.00 THRA (0.41) THRATHRBTLR8MEN1NR1I2
SCHEMBL5268685 1.00 THRA (0.41) THRATHRBTLR8MEN1NR1I2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4365184-A1 ANALYSIS METHOD FOR PEPTIDE BOUND TO CARRIER FOR LIQUID PHASE PEPTIDE SYNTHESIS Peptistar Inc. (JP) 2024-05-08 — — EP disclosed
EP-3778621-B1 PEPTIDE SYNTHESIS METHOD JITSUBO CO LTD (JP) 2023-08-23 — — EP disclosed
WO-2023033017-A1 METHOD FOR PRODUCING GANIRELIX OR SALT THEREOF 積水メディカル株式会社 2023-03-09 — — WO disclosed
WO-2023033015-A1 METHOD FOR PRODUCING FMOC-PROTECTED AMINO GROUP-CONTAINING COMPOUND 積水メディカル株式会社 2023-03-09 — — WO disclosed
WO-2023033016-A1 ARGININE DERIVATIVE 積水メディカル株式会社 2023-03-09 — — WO disclosed
WO-2023277186-A1 ANALYSIS METHOD FOR PEPTIDE BOUND TO CARRIER FOR LIQUID PHASE PEPTIDE SYNTHESIS ペプチスター株式会社 2023-01-05 — — WO disclosed
CN-107406480-B Peptide synthesis method JITSUBO株式会社 2022-06-24 — — CN disclosed
CN-113717239-A Precipitation accelerator and precipitation method using the same 味之素株式会社 2021-11-30 — — CN disclosed
CN-107207555-B Precipitation accelerator and precipitation method using the same 味之素株式会社 2021-10-22 — — CN disclosed
US-20210139532-A1 PEPTIDE SYNTHESIS METHOD JITSUBO CO., LTD. (JP) 2021-05-13 — — US disclosed
US-20170320904-A1 PRECIPITATION PROMOTER AND PRECIPITATION METHOD IN WHICH SAME IS USED AJINOMOTO CO., INC. (JP) 2017-11-09 — — US disclosed
US-9206230-B2 Benzylic compound AJINOMOTO CO., INC. (JP) 2015-12-08 — — US disclosed
US-20140371424-A1 BENZYLIC COMPOUND AJINOMOTO CO., INC. (JP) 2014-12-18 — — US disclosed
US-8859732-B2 Benzylic compound AJINOMOTO CO., INC. (JP) 2014-10-14 — — US disclosed
EP-2684888-A1 NOVEL CROSS-LINKED PEPTIDES CONTAINING NON-PEPTIDE CROSS-LINKED STRUCTURE, METHOD FOR SYNTHESIZING CROSS-LINKED PEPTIDES, AND NOVEL ORGANIC COMPOUND USED IN METHOD Jitsubo Co., Ltd. (JP) 2014-01-15 — — EP disclosed
EP-2518041-A1 BENZYL COMPOUND Ajinomoto Co., Inc. (JP) 2012-10-31 — — EP disclosed
US-20110160433-A1 BENZYLIC COMPOUND AJINOMOTO CO., INC. (JP) 2011-06-30 — — US disclosed
US-20100184952-A1 METHOD FOR SELECTIVE REMOVAL OF DIBENZOFULVENE DERIVATIVE AJINOMOTO CO., INC (JP) 2010-07-22 — — US disclosed
EP-2181983-A1 METHOD FOR SELECTIVE REMOVAL OF DIBENZOFULVENE DERIVATIVE Ajinomoto Co., Inc. (JP) 2010-05-05 — — EP disclosed
EP-1843407-A1 Liquid crystalline rylenetetracarboxylic acid derivatives and their use BASF AKTIENGESELLSCHAFT (DE) 2007-10-10 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210139532-A1 PEPTIDE SYNTHESIS METHOD NPPA, ANPEP, VIP THRA 980/4885THRB 1405/4885TLR8 3176/4885
US-20110160433-A1 BENZYLIC COMPOUND VIP, NGLY1, FURIN THRA 3778/4885THRB 3133/4885TLR8 3830/4885
US-20140371424-A1 BENZYLIC COMPOUND VIP, NGLY1, FURIN THRA 3778/4885THRB 3133/4885TLR8 3830/4885
US-20170320904-A1 PRECIPITATION PROMOTER AND PRECIPITATION METHOD IN WHICH SAME IS USED SP1, MED25, CTCF THRA 4084/4885THRB 3519/4885TLR8 3606/4885
US-20100184952-A1 METHOD FOR SELECTIVE REMOVAL OF DIBENZOFULVENE DERIVATIVE DDC, DNPEP, DBF4 THRA 3221/4885THRB 2265/4885TLR8 3894/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.